IsoPlexis Corporation (ISO)

$1.32

+0.02 (+1.54%)
Rating:
Recommendation:
-
Symbol ISO
Price $1.32
Beta 0.000
Volume Avg. 0.98M
Market Cap 53.235M
Shares () -
52 Week Range 0.602-7.5
1y Target Est -
DCF Unlevered ISO DCF ->
DCF Levered ISO LDCF ->
ROE -200.15% Strong Sell
ROA -103.50% Strong Sell
Operating Margin -
Debt / Equity 83.46% Buy
P/E 0.14 Neutral
P/B 0.71 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ISO news


Healthcare
Medical Devices
NASDAQ Global Select

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.